Target intelligence / Profile preview

Lipopolysaccharide degradation pathway

Molecular classification
Other (metabolic pathway)
01

Overview

The lipopolysaccharide degradation pathway, sometimes referred to as LPS detoxification, is not a single molecule or receptor but rather a series of enzymatic processes that break down bacterial lipopolysaccharides (LPS), which are major components of the outer membrane in Gram-negative bacteria. These pathways are crucial for host defense because intact LPS is a potent endotoxin that triggers strong inflammatory responses via receptors such as TLR4/MD2/CD14 on host cells. Key enzymes involved include acyloxyacyl hydrolase (AOAH)—which removes secondary acyl chains from lipid A, reducing its toxicity—and intestinal alkaline phosphatase, which dephosphorylates lipid A to further diminish its pro-inflammatory effects. The proper functioning of these pathways helps restore homeostasis after exposure to bacterial endotoxins and prevents excessive inflammation and related pathologies such as sepsis and chronic inflammatory diseases[3].

02

Mechanism of action

Enzymatic cleavage or modification of lipopolysaccharide molecules to reduce their endotoxic activity

03

Biological functions

Degradation of bacterial lipopolysaccharidesDetoxification of endotoxinsModulation of immune response
04

Disease associations

Infection (indirectly, through modulation of LPS toxicity and immune response)Inflammation (indirectly, via LPS detoxification)
05

Safety considerations

None specific to the pathway itself; however, incomplete degradation can result in persistent inflammation or immune activation
06

Biomarkers

Activity or presence of enzymes such as acyloxyacyl hydrolase (AOAH) and intestinal alkaline phosphatase may serve as indirect biomarkers for LPS degradation capacity

Beyond the preview

Go deeper on Lipopolysaccharide degradation pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide degradation pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call